AI in Oncology: From Promise to Clinical Integration

An unprecedented view of the immune system’s killer cells

Camilla Jandus is awarded the Robert Wenner Prize

Rethinking ovarian cancer III: the past decade and future directions

The Tumor Hacker: How Data & AI Are Rewriting the Future of Oncology

Professor Olivier Michielin Discusses mRNA Advances in Le Temps

Patrycja Nowak-Sliwinska was awarded the prestigious European Certified Pharmacologist (EuCP) designation

Denis Migliorini has been promoted to Associate Professor

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors

Revolutionising oncology through precision medicine

Camilla Jandus: "Our immune defences are still far from having revealed all their secrets"

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer